Does LUMASIRAN Cause Off label use? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Off label use have been filed in association with LUMASIRAN (OXLUMO). This represents 2.2% of all adverse event reports for LUMASIRAN.
6
Reports of Off label use with LUMASIRAN
2.2%
of all LUMASIRAN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Off label use From LUMASIRAN?
Of the 6 reports, 1 (16.7%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LUMASIRAN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does LUMASIRAN Cause?
Renal transplant (38)
Nephrolithiasis (22)
Drug ineffective (15)
Hospitalisation (15)
Urine oxalate increased (14)
Acute kidney injury (11)
Liver transplant (11)
Laboratory test abnormal (9)
Product dose omission issue (9)
Death (8)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LUMASIRAN Alternatives Have Lower Off label use Risk?
LUMASIRAN vs LUMATEPERONE
LUMASIRAN vs LUMIGAN
LUMASIRAN vs LUPRON DEPOT
LUMASIRAN vs LUPRON DEPOT-PED
LUMASIRAN vs LURASIDONE